Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 30,00 € Taxes included to order
    Pages Iconography Videos Other
    2 0 0 0

Joint Bone Spine
Volume 79, n° 2
pages 200-201 (mars 2012)
Doi : 10.1016/j.jbspin.2011.07.001
accepted : 5 July 2011
Antiphospholipid syndrome development after rituximab treatment

César Faillace, Jozélio Freire de Carvalho
Rheumatology Division, Clínica de Oncologia (CLION), 119, 7 andar Salvador, 41810-570 Bahia, Brazil 

Corresponding author. Tel.: +55 71 21 05 65 65; fax: +55 11 21 05 65 55.

Keywords : Stroke, Systemic lupus erythematosus, Antiphospholipid syndrome, Rituximab

© 2011  Société française de rhumatologie@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline